English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/126865
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

New oleyl glycoside as anti-cancer agent that targets on neutral sphingomyelinase

AuthorsRomero-Ramírez, Lorenzo ; García-Álvarez, Isabel; Casas Brugulat, Josefina; Barreda-Manso, M. Asunción ; Yanguas-Casás, Natalia; Nieto-Sampedro, Manuel ; Fernández-Mayoralas, Alfonso
KeywordsSphingomyelin
ER stress
Ceramide
Glycosphingolipids
Apoptosis
Issue Date2015
PublisherElsevier
CitationBiochemical Pharmacology 97: 158-172 (2015)
AbstractWe designed and synthesized two anomeric oleyl glucosaminides as anti-cancer agents where the presence of a trifluoroacetyl group close to the anomeric center makes them resistant to hydrolysis by hexosaminidases. The oleyl glycosides share key structural features with synthetic and natural oleyl derivatives that have been reported to exhibit anti-cancer properties. While both glycosides showed antiproliferative activity on cancer cell lines, only the α-anomer caused endoplasmic reticulum (ER) stress and cell death on C6 glioma cells. Analysis of sphingolipids and glycosphingolipds in cells treated with the glycosides showed that the α-anomer caused a drastic accumulation of ceramide and glucosylceramide and reduction of lactosylceramide and GM3 ganglioside at concentrations above a threshold of 20 μM. In order to understand how ceramide levels increase in response to α-glycoside treatment, further investigations were done using specific inhibitors of sphingolipid metabolic pathways. The pretreatment with 3-O-methylsphingomyelin (a neutral sphingomyelinase inhibitor) restored sphingomyelin levels together with the lactosylceramide and GM3 ganglioside levels and prevented the ER stress and cell death caused by the α-glycoside. The results indicated that the activation of neutral sphingomyelinase is the main cause of the alterations in sphingolipids that eventually lead to cell death. The new oleyl glycoside targets a key enzyme in sphingolipid metabolism with potential applications in cancer therapy.
Publisher version (URL)http://dx.doi.org/10.1016/j.bcp.2015.07.009
URIhttp://hdl.handle.net/10261/126865
DOI10.1016/j.bcp.2015.07.009
Identifiersdoi: 10.1016/j.bcp.2015.07.009
issn: 0006-2952
e-issn: 1873-2968
Appears in Collections:(IQOG) Artículos
(IQAC) Artículos
(IC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.